Shamrock Group is a prominent manufacturer in the pharmaceutical industry, specialising in the production of Active Pharmaceutical Ingredients (APIs), Intermediates, and Fine Chemicals. With significant expertise in regulatory affairs and containment, the company is well-equipped to deliver high-quality products that meet stringent global standards. Shamrock Pharma Group boasts ownership of four manufacturing facilities and three research and development laboratories, alongside a pilot plant dedicated to Contract Research and Manufacturing Services (CRAMS). With over 23 years of experience in manufacturing and exporting APIs, Intermediates, and veterinary products to over 40 countries, Shamrock Group recently expanded its capabilities by acquiring Unimark Remedies and Carbapenem Facilities, enhancing its portfolio from basic manufacturing to sterile injectable vials.

Services include:
– APIs (Active Pharmaceutical Ingredients)
– Intermediates
– Fine Chemicals
– Regulatory Services
– Containment

As a committed partner in improving public health, Shamrock Group delivers innovative solutions that significantly contribute to the pharmaceutical landscape. For more information, please visit shamrockindia.com.